Perspective Therapeutics, Inc. (CATX) Builds Momentum With Funding and Trial Progress

Perspective Therapeutics Inc. (NYSE:CATX) is one of the best high-return penny stocks to buy right now. On February 2, Perspective Therapeutics Inc. (NYSE:CATX) priced an underwritten offering of 39.57 million shares at $3.78 per share. Perspective Therapeutics, Inc. (CATX) Builds Momentum With Funding and Trial Progress The company anticipates gross proceeds of $175 million from the offering. It plans to use the net proceeds from the offering to advance the clinical development of its product candidates ...